HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Khalil Ghasemi Falavarjani Selected Research

Retinal Hemorrhage

12/2010Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Khalil Ghasemi Falavarjani Research Topics

Disease

5Macular Degeneration (Age-Related Maculopathy)
02/2024 - 04/2014
5Macular Edema
01/2018 - 07/2012
4Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020 - 06/2016
2Endophthalmitis (Ophthalmia)
04/2022 - 08/2017
2Retinal Detachment (Retinal Detachments)
01/2022 - 04/2017
2Retinal Vein Occlusion
01/2018 - 01/2017
2Ganglion Cysts (Ganglion)
08/2017 - 12/2016
2Retinopathy of Prematurity (Retrolental Fibroplasia)
10/2013 - 12/2010
1Central Serous Chorioretinopathy
01/2024
1Choroidal Effusions
07/2023
1Stargardt Disease
07/2023
1Cysts
01/2020
1Open-Angle Glaucoma (Glaucoma, Open Angle)
08/2017
1Ischemia
05/2017
1Vascular Remodeling
12/2016
1Atrophy
12/2016
1Thalassemia
12/2016
1Hemoglobinopathies
12/2016
1Degenerative Myopia
12/2014
1Carcinoma (Carcinomatosis)
12/2014
1Myocardial Infarction
12/2014
1Choroidal Neovascularization
12/2014
1Stroke (Strokes)
12/2014
1Pain (Aches)
04/2013
1Cataract (Cataracts)
04/2012
1Retinal Hemorrhage
12/2010
1Blindness (Hysterical Blindness)
01/2009

Drug/Important Bio-Agent (IBA)

11Retinaldehyde (Retinal)IBA
04/2022 - 01/2009
4Fluorescein (Funduscein)FDA LinkGeneric
01/2024 - 06/2016
3Bevacizumab (Avastin)FDA Link
12/2014 - 12/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 12/2014
1Biosimilar PharmaceuticalsIBA
02/2024
1afliberceptIBA
02/2024
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2024
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2024
1oxane HDIBA
04/2017
1densironIBA
04/2017
1Hemoglobins (Hemoglobin)IBA
12/2016
1Methotrexate (Mexate)FDA LinkGeneric
02/2016
1Ranibizumab (Lucentis)FDA Link
12/2014
1Complement Factor H (Factor H)IBA
04/2014
1Ophthalmic Solutions (Eye Drops)IBA
04/2013
1homatropineIBA
04/2013

Therapy/Procedure

3Vitrectomy
01/2022 - 04/2012
2Therapeutics
07/2023 - 01/2017
2Intravitreal Injections
02/2016 - 12/2010
1Photochemotherapy (Photodynamic Therapy)
01/2024
1Injections
07/2023
1Intraocular Lenses (Intraocular Lens)
08/2017
1Semiconductor Lasers
10/2013
1Light Coagulation
10/2013
1Photorefractive Keratectomy
04/2013
1Phacoemulsification
04/2012
1Laser Therapy (Surgery, Laser)
12/2010